相关实验视频

Updated: May 9, 2025

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

长非编码RNACRNDE 通过诱导M2型巨细胞的极化,促进质瘤的发展

Liang Sun^1,2, Zhi Yang^1,3,2, Haibin Chen^1,2

¹Department of Neurosurgery, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang Province, China.

Molecular neurobiology

|May 4, 2025

概括

长非编码RNACRNDE通过影响瘤相关的巨细胞来促进质瘤的进展. 增加的lncRNA-CRNDE表达与质瘤患者的预后不佳和生存率降低相关,将其确定为潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

质瘤是一种常见的大脑瘤,由于其复杂的瘤微环境 (TME),预后不佳.
现有的治疗方法提供了有限的患者存活率,需要进一步的分子研究.
长非编码RNACRNDE (lncRNA-CRNDE) 在质瘤进展中的作用,特别是它与瘤相关的巨细胞的相互作用,仍然不清楚.

研究的目的:

研究lncRNA-CRNDE在促进结质瘤进展中的作用.
确定lncRNA-CRNDE是否在TME内调节与瘤相关的巨细胞.
评估lncRNA-CRNDE作为结质瘤的预后标记物和潜在的治疗点.

主要方法:

在TCGA数据库中分析IncRNA-CRNDE表达和质瘤的预后意义.
在临床质瘤样本上使用RT-qPCR,西式斑点和ELISA.
细胞生物学技术分析对质瘤扩散和侵袭的影响.
动物模型实验验证 lncRNA-CRNDE 在质瘤进展和巨细胞两极分化中的作用.

主要成果:

与正常组织相比,在质瘤组织中观察到更高的lncRNA-CRNDE表达,与更差的预后相关.
临床样本中 lncRNA-CRNDE 水平升高与患者存活时间减少有关.
lncRNA-CRNDE促进了质瘤细胞的增殖和侵入,与TME调节和M2巨细胞的偏离有关.
动物模型证实了lncRNA-CRNDE在增强质瘤进展中的作用.

结论:

lncRNA-CRNDE在质瘤中被上调,并与瘤的攻击性行为和不良预后有关.
lncRNA-CRNDE通过影响TME内的巨细胞极化来促进质瘤的进展.
lncRNA-CRNDE代表了潜在的预后生物标志物和治疗质瘤治疗的治疗点.

关键词:

在CRNDE中,您可以使用CRNDE.质瘤是一种质瘤.长的非编码RNA是什么?在M2巨细胞中,M2巨细胞巨细胞的两极分化瘤微环境是一个微环境.

更多相关视频

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...